Page last updated: 2024-10-22

albuterol and Genetic Diseases

albuterol has been researched along with Genetic Diseases in 1 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Research Excerpts

ExcerptRelevanceReference
" Among different strategies conducted to identify this 'missing heritability', here we illustrate the importance of complex gene-environment interactions using findings regarding the role of leukotrienes on the bronchodilator response to albuterol in Latino asthmatics."3.79Role of interactions in pharmacogenetic studies: leukotrienes in asthma. ( González Burchard, E; Tcheurekdjian, H; Via, M, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Via, M1
Tcheurekdjian, H1
González Burchard, E1

Other Studies

1 other study available for albuterol and Genetic Diseases

ArticleYear
Role of interactions in pharmacogenetic studies: leukotrienes in asthma.
    Pharmacogenomics, 2013, Volume: 14, Issue:8

    Topics: Albuterol; Alleles; Asthma; Biomarkers, Pharmacological; Bronchodilator Agents; Gene-Environment Int

2013